Skip to main content

Mubadala — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

101
Companies
$15.7B
Total invested
$308.0M
Avg. check
57
Industries
Health Care 6Medical 5Financial Services 4Biotechnology 4Information Technology 3Telecommunications 3+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 101
CERC Central de Recebíveis
October 2022

CERC is the winning platform for Financial Market Infrastructure in Brazil assembling tech-enabled solutions to foster credit access.

Financial Services · São Paulo$105.3M Venture - Series Unknown
beans.ai
October 2021

Last-mile mapping leader that offers location intelligence at unparalleled accuracy and coverage.

Software · Palo Alto$17.0M Seed
Electra Therapeutics
October 2025

Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.

Biotechnology · San Francisco$183.0M Series C
Halo Investing
October 2021

Halo Investing is a financial technology platform that provides structured note investments to the average investor.

Finance · Chicago$100.0M Series C
Flink
March 2026

Flink is an online startup that offers grocery deliveries in ten minutes.

E-Commerce · Berlin$100.0M Series Unknown
Salma Health
February 2026

Salma Health is a concierge neurocognitive clinic that uses neurology and psychiatry techniques to solve various brain conditions.

Health Care · La Jolla$80.0M Series A
Yondr Group
February 2026

Yondr Group is a developer, owner operator and service provider of data centers.

Information Services · Amsterdam$717.1M Debt Financing
Juvena Therapeutics
January 2026

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

Biopharma · Redwood City$33.5M Series B
Orca Bio
January 2026

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Health Care · Menlo Park$250.0M Series F
Avanse Financial Services
January 2026

Avanse Financial Services is an education-focused non-banking financial company that offers education loans.

Education · Mumbai$133.3M Private Equity
Rezolv Energy
December 2025

Rezolv Energy develops, owns, and operates renewable power generation assets focused on large-scale wind and solar projects.

Energy · Prague$352.9M Private Equity
MGT Insurance
October 2025

MGT Insurance provides insurance experience for the sales partners and policyholders.

Consulting · Greenwood Village$21.6M Series B
Ollin Biosciences
September 2025

Ollin Biosciences operates as a clinical-stage biopharmaceutical company.

Biopharma · Austin$100.0M Series A
BrightSpeed
September 2025

Brightspeed provides fiber and broadband services, enhancing connectivity for homes and businesses with reliable telecom solutions.

Internet · Charlotte$13.8M Grant
Welcome Tech
August 2025

Welcome Tech is a digital platform that builds data-driven services for immigrant workforces.

Banking · Los Angeles$7.5M Series Unknown
Holo
August 2025

Holo is an end to end property buying platform that supports mortgage search, comparison, and application.

Financial Services · Dubai$22.0M Series A
Paragraf
August 2025

Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.

Advanced Materials · Somersham$55.0M Series C
Aligned
August 2025

Aligned is a data center infrastructure technology company that provides build-to-scale and pre-commissioned colocation solutions.

Cloud Infrastructure · Plano$400.0M Debt Financing
Anaconda
July 2025

Anaconda is an open-source distribution of the Python and R programming languages for data science that simplifies package management.

Analytics · Austin$150.0M Series C
Lyell Immunopharma
July 2025

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Biotechnology · South San Francisco$100.0M Post Ipo Equity
CityFibre
July 2025

CityFibre operates as an independent provider of fiber infrastructure in secondary cities.

Infrastructure · London$1.3B Debt Financing
Arbol
June 2025

Arbol is a climate risk coverage company that offers solutions to analyze .and mitigate exposure to climate risk.

Agriculture · New York$100K Convertible Note
3650 Capital
March 2025

3650 Capital is a CRE lending and loan servicing firm.

Commercial Real Estate · Miami$215.0M Undisclosed
Light Horse Therapeutics
January 2025

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology · San Diego$62.0M Series A

Where Mubadala invests

Health Care6
Medical5
Financial Services4
Biotechnology4
Information Technology3
Telecommunications3

About Mubadala's portfolio

How many companies has Mubadala invested in?

Mubadala has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Mubadala invest in?

Mubadala's top investment sectors include Health Care, Medical, Financial Services, Biotechnology, Information Technology. The firm invests across 57 different industry categories.

What is Mubadala's largest investment?

Among tracked funding rounds, CityFibre received $1.3B in a Debt Financing round. Mubadala's total known invested capital is $15.7B.

What is the average investment size for Mubadala?

Mubadala's average investment size is $308.0M across its portfolio of 101 companies.

What are Mubadala's most recent investments?

Recent Mubadala portfolio additions include CERC Central de Recebíveis, beans.ai, Electra Therapeutics, Halo Investing, Flink. These companies were founded in 2020 or later.

Reach the founders behind these 101 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →